Source link : https://www.newshealth.biz/health-news/glp-1s-dont-increase-neurologic-psychiatric-risk/
An analysis based on a massive database of US electronic health records (EHRs) adds to evidence favoring the safety of glucagon-like peptide 1 (GLP-1) medications, finding no increased risk for many neurologic and psychiatric ailments when semaglutide was compared with other diabetes drugs. Riccardo De Giorgi, MD, DPhil, of the University of Oxford, Oxford, England, […]
Author : News Health
Publish date : 2024-07-17 09:31:53
Copyright for syndicated content belongs to the linked Source.
Categories